“Pediatric EEG Montages in Clinical Practice” – Webinar
Presented by Giridhar Kalamangalam, MD
Thursday, August 27, 5 – 6 PM CDT
Webinar Goals & Objectives
– Gain insight into the relative merits and demerits of different montages
– Sharpen skills on the principles of analysis of EEG waveforms in different montagesto localize normal and abnormal brain activity
– Observe these principles in action in common epilepsy syndromes
After registering, you will receive a Zoom confirmation email containing information about joining the webinar.
Giridhar Kalamangalam, MD
|Giridhar Kalamangalam, MD, DPhil, is a Wilder Family endowed professor and the Division Chief of Epilepsy at the UF College of Medicine. Dr. Kalamangalam’s career has been devoted to the care of patients with epilepsy, and research in the science of, and around, epilepsy.|
Key Considerations for Choosing AED Therapy
Presented by R. Eugene Ramsay, MD
Webinar Goals & Objectives
– Review the pharmacology of AEDs and the elements that are pivotal to selection and performance
– Discuss treatment strategies to improve patient adherence
– Provide additional knowledge of the mechanisms of action of AEDs to help improve drug selection
Watch webinar below
R. Eugene Ramsey, MD
Dr. Ramsay is a Fellow of the American Academy of Neurology, and a member of the American Electroencephalographic Society, the American Epilepsy Society, and the American Neurological Association. Dr. Ramsay has trained 28 fellows during his time and several are now leading epileptologists at other epilepsy centers.
Dr. Ramsay is chief editor of the book Neurobiology of Epilepsy and Aging and with A. James Rowan, of the textbook Seizures and Epilepsy in the Elderly. He is author or co-author of more than 120 articles published in peer-reviewed journals, 28 book chapters, and a book.
He is the recipient of more than 80 grants for research in the treatment of epilepsy. One of his leading accomplishments has been the completion of a large multicenter study on the treatment of epilepsy in a geriatric population.
The Epileptic Heart
Sudden unexpected death in epilepsy (SUDEP) is generally considered to result from a seizure. Recent clinical evidence indicates a 3-fold greater chance of sudden cardiac death in patients with chronic epilepsy than in the general population. In 66% of these cases, the cardiac arrest occurred during routine daily activity without a temporal relationship with a typical seizure.
Stratus | Alliance Neurodiagnostics recently hosted a webinar on The Epileptic Heart presented by Trudy Pang, MD, and Richard Verrier, PhD.
The main goal of this webinar is to introduce the concept of “The Epileptic Heart” and to review the supporting evidence and discuss the clinical implications that could impact on practice.
• To provide a working definition of “The Epileptic Heart”;
• To review briefly the underlying pathophysiology and recent publications supporting the validity of this clinical entity;
• To introduce new tools, such as patient-friendly EKG patches for at-home monitoring and T-wave alternans for sudden cardiac death risk stratification, which identifies risk for development of “the epileptic heart”;
• To discuss the practical clinical implications of the recent discoveries related to “The Epileptic Heart.”
Watch webinar below
Dr. Trudy Pang is an Assistant Professor of Neurology at Harvard Medical School and Director of Clinical Neurophysiology and Adult Epilepsy Fellowship at Beth Israel Deaconess Medical Center. She is also the Director of the comprehensive Women’s Health in Epilepsy Program, a collaborative effort across Boston medical institutions to address the special needs of women with epilepsy.
Dr. Richard Verrier is an Associate Professor of Medicine, Division of Cardiovascular Medicine, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center. He has investigated sudden cardiac death for more than three decades, having published more than 300 original articles. He is an inventor of 12 licensed patents for diagnosis and treatment of heart rhythm abnormalities and prediction of sudden cardiac death.
Intractable Epilepsy in Children:
Evaluation and Treatment Options
Most children with epilepsy achieve reasonably good seizure control with antiepileptic drug therapy. It is estimated that 10-20% of children with epilepsy do not respond though, and have refractory epilepsy. This can have a profound effect on the education, social, emotional, and cognitive functioning of the child.
Stratus | Alliance Neurodiagnostics recently hosted a webinar on Intractable Epilepsy in Children presented by Gretchen Von Allmen, MD.
In this webinar, Dr. Von Allmen:
• Defines intractable epilepsy, and understand incidence, causes, and impact in children
• Discusses goals of evaluation and means of testing; understand the role of Comprehensive Epilepsy centers
• Reviews non-medication and surgical treatments for intractable epilepsy, including ketogenic diet, neurostimulators (VNS, RNS), invasive EEG, laser ablation, corpus callosotomy, resection/lobectomy, and hemispherotomy
Watch webinar below
Dr. Von Allmen has been the Director of the Pediatric Epilepsy Program and Medical Director of the Pediatric Epilepsy Monitoring Unit at the University of Texas Health Science Center at Houston for more than 12 years. Dr. Von Allmen earned her medical degree at Emory University School of Medicine, and completed residencies at Emory and Northwestern University, as well as fellowships at the University of Chicago and Baylor College of Medicine. She has expertise evaluating children undergoing non-invasive and invasive procedures for epilepsy surgery, namely in the utilization and interpretation of Stereo-EEG and Magnetoencephalography. She has published peer-reviewed articles in Epilepsia and Nature, and also contributed to the writing of a book chapter on Vagus Nerve Stimulation (VNS) for Intractable Epilepsy. Dr. Von Allmen is an editorial ad-hoc reviewer for the Journal of Clinical Neurophysiology and sits on the board of the Epilepsy Foundation of Texas, Houston chapter.
PNES are the most common condition misdiagnosed as epilepsy. They account for approximately 20-30% of EMU admissions for refractory epilepsy, and they are nearly as prevalent as multiple sclerosis and trigeminal neuralgia in the general population. “In addition to being common, psychogenic symptoms pose an uncomfortable and often frustrating challenge, both in diagnosis and management.” ~ Selim R. Benbadis, M.D.
Stratus | Alliance Neurodiagnostics recently hosted a webinar on PNES with Dr. Benbadis, a leader in the study of PNES.
Dr. Benbadis reviews:
• The diagnosis of psychogenic seizures
• The various psychiatric diagnoses underlying psychogenic seizures
• The basic principles of treatment for psychogenic seizures
This webinar will only be available for a limited time.
Selim Benbadis, M.D. is board-certified in Neurology, Epilepsy and Clinical Neurophysiology, and Sleep Medicine. He is Division Director, Epilepsy, EEG & Sleep Medicine and a Professor of Neurology at the University of South Florida. He is also Director of the Comprehensive Epilepsy Center at Tampa General Hospital.
To learn more about Stratus and our suite of home EEG testing and video EEG monitoring solutions, or to schedule a demo, please fill out the form below.